Atopic dermatitis in elderly adults (notice n° 602148)
[ vue normale ]
000 -LEADER | |
---|---|
fixed length control field | 02386cam a2200253 4500500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250121154410.0 |
041 ## - LANGUAGE CODE | |
Language code of text/sound track or separate title | fre |
042 ## - AUTHENTICATION CODE | |
Authentication code | dc |
100 10 - MAIN ENTRY--PERSONAL NAME | |
Personal name | Dezoteux, Frédéric |
Relator term | author |
245 00 - TITLE STATEMENT | |
Title | Atopic dermatitis in elderly adults |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Date of publication, distribution, etc. | 2019.<br/> |
500 ## - GENERAL NOTE | |
General note | 43 |
520 ## - SUMMARY, ETC. | |
Summary, etc. | Background: Atopic dermatitis (AD) in adults over 45 years of age (AD≥45) has been poorly studied. Objectives: To determine whether the AD phenotype varies according to the pattern of AD onset in AD≥45 patients and whether response to cyclosporine A (CsA) is influenced by age. Materials and Methods: This monocentric retrospective study was performed in a French university department of dermatology. We included 409 AD<45 patients (111 treated with CsA) and 124 AD≥45 patients (26 treated with CsA). Among AD≥45 patients, 20% were categorised into Subgroup 1 (persistence of AD since childhood), 52% into Subgroup 2 (recurrence of AD with a history of classic childhood AD), and 28% into Subgroup 3 (adult-onset AD). Results: Gender, associated atopic comorbidities, a family history of atopy, and AD severity were similar regarding the different patterns of AD onset in AD≥45 patients. Skin lesions predominated on the face and neck in AD≥45 patients with AD since childhood (30% in Subgroups 1 and 2) compared to those with adult-onset AD (14% in Subgroup 3). The efficacy of CsA was similar between groups AD≥45 and AD<45, but 28% of AD≥45 patients versus 20% of AD<45 patients had increased serum creatinine levels under CsA. Conclusion: No significant association seems to exist between the onset of AD and demographic or clinical characteristics in AD≥45 patients (except that head and neck involvement is rarer in adult-onset AD). Patient age does not influence response to CsA, but this drug appears to be less well tolerated in older patients. |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | adults |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | atopic dermatitis |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | cyclosporine A |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Astrid, Bellissen |
Relator term | author |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Chuffard, Marie |
Relator term | author |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Drumez, Elodie |
Relator term | author |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Azib, Selma |
Relator term | author |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Staumont-Sallé, Delphine |
Relator term | author |
786 0# - DATA SOURCE ENTRY | |
Note | European Journal of Dermatology | 29 | 4 | 2019-07-01 | p. 371-374 | 1167-1122 |
856 41 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://shs.cairn.info/revue-european-journal-of-dermatology-2019-4-page-371?lang=en&redirect-ssocas=7080">https://shs.cairn.info/revue-european-journal-of-dermatology-2019-4-page-371?lang=en&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux